A avaliação do uso da toxina botulínica A e da cinesioterapia na melhora da marcha do portador de paralisia cerebral do tipo hemiparético
DOI:
https://doi.org/10.11606/issn.2317-0190.v8i3a102350Keywords:
Cerebral Palsy, Botulinum Toxins, Type A, Physical Therapy, GaitAbstract
It was studied 14 spastic hemiparetic patients, with dynamic equines and age between 3 and 9 years old. The patients were distributed in 2 groups: Group I – 7 children that received botulinum toxin type A (BTX A) injections in the gastrocnemius and soleus muscles and also kinesiotherapic treatment; Group II – 7 children that received only the kinesiotherapic treatment. The data analysed were: the ankle range of motion, muscle tone, the action of tibialis anterior muscle, the velocity, cadence and the gait observational analysis and the parents degree of satisfaction. The statistical analysis showed that in Group I all data were improved in a short time. In Group II the data were not improved in the same period of time, but there were some improvements on some data in a longer period of time.
Downloads
References
Nelson KB. Epidemiology of cerebral palsy. In: Levene MI, Lilford RJ, Bennet MJ, Punt J. Fetal and neonatal neurology and neurosurgery. London: Churchill-Livingstone; 1995.
Gomes C, Santos CA, Silva JU, Lianza S. Paralisia cerebral. In: Lianza S. Medicina de reabilitação. 2nd ed. Rio de Janeiro: Guanabara Koogan; 1995. p.288-303.
Souza ACM. Prognóstico funcional da paralisia cerebral. In: Souza ACM, Ferraretto I. Paralisia cerebral: aspectos práticos. São Paulo: Menon; 1998. p.33-7.
Boyd RN, Graham HK. Objective measurement of clinical findings in the botulinum toxim A for the manegement in children with cerebral palsy. Eur J Neurol. 1999; Suppl 4:523-35.
Molnar G, Gordon S. Cerebral palsy predictive values of selected clinical signs for early prognostication of motor function. Arch Phys Med Rehabil. 1976;57(5):153-8.
Souza AMC, Ferraretto I. Fatores que interferem no prognóstico de deambulaçao na paralisia cerebral. Arq Neuropsiq. 1992;50(1):80-3.
Bobath B, Bobath K. Dessarolo motor en distintos tipos de paralisis cerebral. Buenos Aires: Panamericana; 1987.
Sutherland DH, Kaufman KR, Wyatt MD, Chambers HG, Murabak SJ. Double-blind study of botulinum A toxin into gastrocnemius muscle in patients with cerebral palsy. Gait Posture. 1999;10(1):1-9.
Gage JR. Gait analysis in cerebral palsy. New York: Mackeith Press; 1991.
Perry J. Gait analysis: normal and pathological function. New Jersey: Slack; 1992.
Prat J. Biomecanica de la marcha humana normal . In: Prat J. Biomecanica de la marcha humana normal y patologica. Valência: Hispânica; 1993. p.19-42.
Davids JR, Foti T, Dabelstein J, Bagley A. Voluntary (normal) versus obligatory (cerebral palsy) toe-walking in children: a kinematic, kinetic and electromyographic analysis. J Ped Orthop. 1999;19:461-9.
Selber PR. Análise de marcha em paralisia cerebral. In: Souza AMC, Ferrareto I. Paralisia cerebral: aspectos práticos. São Paulo: Menon; 1998. p. 47-62.
Winters TF, Gage JR, Hickis R. Gait pattern in spastic hemiplegia in children and young adults. J Bone Joint Surg. 1987;(A)69:437-41.
Gusman S, Torre CA. Fisioterapia em paralisia cerebral. In: Souza AMC, Ferraretto I. Paralisia cerebral: aspectos práticos. São Paulo: Menon; 1998. p.169-206.
Boyd RN, Pliatsios V, Starr R, Wolfe R, Graham HK. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Gait Posture. 1998;7:166.
Koman A, Mooney JF, Smith BP. Neuromuscular blocked in the management of cerebral palsy. J Child Neurol. 1996;(11):suppl 523-8.
Spositto MMM, Conoratcki S. Paraparesia espástica familiar: tratamento da espasticidade através de bloqueio com toxina botulínica do tipo A Botoxr e fenol. Med Reabil. 1997;45:9-14.
Corry IS, Cosgrove AP, Duffy C, McNeill S, Taylor T, Graham HK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial. J Ped Orthop. 1998;18(3):304-11.
Flett PJ, Stern LM, Waddy H, Connell TM, Seeger J, Gibson S. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Ped Child Health. 1999;(1):35(1):71-7.
Galli M, Motta F. Gait analysis in the evaluation of botulinum toxin A treatment. Dev Med Child Neurol. 1998;(suppl 78):28.
Sutherland DH. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3 dimensional motion analysis study. Gait Posture. 1996;4:269-79.
Eames N, Baker R, Cosgrove A, McNeill S, Graham HK, Taylor T, et al. The effect of botulinum toxin A injection on gastrocnemius muscle growth in the children with cerebral palsy. Dev Med Child Neurol. 1996;(suppl 74):23-4.
Grahamm HK, Aoki RR, Ramö I, Boyd RN, Delgado M, Deborah J, et al. Reccomendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture. 2000;11(1):67-79.
Albany K. Physical and occupational therapy considerations in adult patient receiving botulinum toxin for spasticity. Muscle Nerve. 1997;(suppl 6):S221-8.
Leach J. Children undergoing treatment with botulinum toxin: the role of the physical the rapist. Muscle Nerve. 1997;(suppl 6):S194-207.
Bohannon RW, Smith MB. Interrater reability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67:206-7.
Hoyos JV, Lafuente R, Lacuesta JS, Prat J, Gracia CS. El laborato rio de análisis de la marcha humana. In: Prat J. Biomecanica de la marcha humana normal y patologica. Valência: Hispanica; 1997. p.324-58.
Malouin F. Observational gait analysis: In: Craik RL, Oatis C. Gait analysis: theory and application. St. Louis: Mosby; 1995.
Smidt GL. Gait assessment and training in clinical practice. In: Smidt GL. Gait in rehabilitation. New York: Churchill- Livingstone; 1990. p:301-15.
Fossberg H, Tedroff KB. Botulinum toxin treatment in cerebral palsy, intervention with poor evaluation? Dev Med Child Neurol. 1997;39:71-7.
Sutherland DH, Olshen RA, Biden EN, Wyatt MP. The development of mature walking. Oxford: Blacwell Scientific Public; 1988. p. 55-64.
Russman BS, Tillton A, Gormley ME. Cerebral palsy: a rational approach to a treatment protocol and the role of botulinum toxin in treatment. Muscle Nerve. 1997;(suppl 6):S1811-93.
Galli M, Fazzi E, Motta F, Crivellini M. Kinematic and dynamic analysis of the ankle joint in children of cerebral palsy. Funct Neurol. 1999;14(3):135-40.
Koman A, Smith BP, Tingey CT, Mooney JF, Slones S, Naughton MJ. The effect of botulinum toxin type A: injection on the natural history of equinus foot deformity in pediatric cerebral palsy patients. Eur J Neurol. 1999;6(suppl):519-22.
Silva JAT. Tratamento das deformidades em eqüino de pacientes portadores de paralisia cerebral do tipo diplégico espástico mediante injeçao de toxina botulínica A em músculos gastrocêmios [tese]. São Paulo: Universidade Federal de São Paulo; 2000.
Downloads
Published
Issue
Section
License
Copyright (c) 2001 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
